|
|
| Id: | 18512
| | Author: | Bakker, M. I; Hatta, M; Kwenang, A; Van Benthem, B. H. B; Van Beers, S. M; Klatser, P. R; Oskam, L. | | Title: | Prevention of leprosy using rifampicin as chemoprophylaxis.
| | Source: | In: Bakker, Mirjam.Epidemiology and prevention of leprosy: a cohort study in Indonesia^ien. s.l, The Netherlands Leprosy Relief, 2005. p.126-139^bilus, ^btab, ^bgraf.
| | Abstract: | An intervention study was implemented on five Indinesian island highly endemic for leprosy to determine whether rifampicin can be used as chemoprophylaxis to prevent leprosy. The population was actively screened before the intervention and subsequently once a year for three years. In the control group, no chemoprophylaxis was given. In the contact group, chemoprophylaxis was only given to contacts of leprosy patients and in the blanket group to all aligible persons. The cohort consited of 3,965 persons. The yearly incidence rate in the control group was 39/10,000; the cumulative incidence after three years was significantly lower in the blanket group (P=0.031). No difference was found between the contact and the control groups (P=0.93). Whether this apparent reduced leprosy incidence in the first three years in the blanket group is due to a delayed development of leprosy or a complete clearence of infections needs to be determined (AU)^ien.
| | Descriptors: | HANSENIASE/prev
MICROSCOPIA/métodos
DERMATOLOGIA/estatíst
| | Limits: | ESTUDO COMPARATIVO
Humanos
| | Location: | BR191.1; WC335.300, B179e |
|
